CopyFind
LEGALON 150 mg CAPSULAS
हर्बल 🇪🇸 स्पेन

LEGALON 150 mg CAPSULAS

Analogs of LEGALON 150 mg CAPSULAS

Find cheaper analogs and generic equivalents for LEGALON 150 mg CAPSULAS.

Ingredients

सक्रिय अवयव: silymarin

Inactive Ingredients: MANITOL (E-421) 21,85 mg, POLISORBATO 80 4,51 mg


उत्पाद अवलोकन

About LEGALON 150 mg CAPSULAS

LEGALON 150 mg CAPSULAS is a pharmaceutical product formulated to support liver health. This medicine is designed for oral administration and is typically used as a therapeutic agent in patients requiring liver function support. Each capsule contains a standardized extract derived from the milk thistle plant, which has been utilized in clinical settings for its specific biological properties. The product is manufactured to meet strict quality standards to ensure consistency in every dose. Patients should follow the specific instructions provided by their healthcare professional regarding the duration and frequency of use. It is essential to store this medication in a cool, dry place away from direct sunlight to maintain its stability and efficacy over time.

Key Benefits & Uses

  • Supports the maintenance of healthy liver function.
  • Provides a standardized dose of silimarine for consistent therapeutic results.
  • Used as an adjuvant treatment for various liver-related conditions.

Active Ingredient & Action

The active ingredient in LEGALON 150 mg CAPSULAS is silimarine. This compound acts primarily by interacting with liver cell membranes, which helps to stabilize them and protect the cells from various external stressors. It is recognized for its role in supporting the natural regenerative processes of the liver.

Important Notes

Consult your physician before beginning treatment with LEGALON 150 mg CAPSULAS to ensure it is appropriate for your specific medical history. Do not exceed the recommended daily dosage. Keep this medication out of the reach of children at all times.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.